as on October 17, 2025 at 4:01 pm IST
Day's Low
Day's High
0.14%
Downside
1.50%
Upside
52 Week's Low
52 Week's High
22.79%
Downside
69.23%
Upside
as on October 17, 2025 at 4:01 pm IST
Market Cap
₹319.34 Cr
Return on Equity (ROE)
7.9
PE Ratio (TTM)
17.77
Return on capital employed (ROCE)
10.25
Industry PE ratio
41.74
Beta (LTM)
1.2
P/B Ratio
1.53
Dividend Yield
0PEG Ratio
148.1
Quarterly Earnings Growth YOY
7.73
EPS (TTM)
0.8
Sector
Pharmaceuticals
Book Value
7.96
Technical Analysis
Bullish
View Technical Analysis
as on October 17, 2025 at 4:01 pm IST
Gennex Laboratories Ltd in the last 5 years
Lowest (10.10x)
March 23, 2020
Today (17.77x)
October 17, 2025
Industry (41.74x)
October 17, 2025
Highest (86.13x)
August 3, 2018
Today’s Price to Earnings Ratio: 17.77x
Compare market cap, revenue, PE, and other key metrics of Gennex Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 319.34 | 57.14% | 0.58 | 18 | 137 | |
NA | 13.33 | 57.33% | 0.00 | -1 | NA | |
NA | 111.10 | -10.14% | 0.70 | 6 | 318 | |
NA | 172.53 | 99.46% | 0.69 | -14 | 19 | |
BUY | 4,759.02 | -6.59% | 0.66 | 168 | 2,387 |
Investment in Gennex Laboratories Ltd Shares on INDmoney has dropped by -19.66% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Gennex Laboratories Ltd Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Gennex Laboratories Ltd.
Gennex Laboratories Ltd’s net profit jumped 3.85% since last year same period to ₹4.59Cr in the Q1 2025-2026. On a quarterly growth basis, Gennex Laboratories Ltd has generated 97.84% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
Promoters have increased holdings from 19.83% to 23.62% in Jul 2025 quarter
Price Rise
In the last 7 days, Gennex Lab. stock has moved up by 15.8%
Profit Spike
Netprofit is up for the last 2 quarters, 2.32 Cr → 4.59 Cr (in ₹), with an average increase of 49.5% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 10.0% return, outperforming this stock by 47.9%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.3% return, outperforming this stock by 4.7%
Retail Holding Down
Retail Investor have decreased holdings from 80.17% to 76.38% in Jul 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 44.16 Cr → 36.45 Cr (in ₹), with an average decrease of 17.5% per quarter
Organisation | Gennex Laboratories Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
CEO | Arihant Baid |
E-voting on shares | Click here to vote |
Gennex Laboratories Ltd share price today stands at ₹14.04 as on at the close of the market. Gennex Laboratories Ltd share today touched a day high of ₹14.25 and a low of ₹14.02.
Gennex Laboratories Ltd touched a 52 week high of ₹23.76 and a 52 week low of ₹10.84. Gennex Laboratories Ltd share price today i.e. is closed at ₹14.04, which is -40.91% down from its 52 week high and 29.52% up from its 52 week low.
Gennex Laboratories Ltd market capitalisation is ₹319.34 Cr as on .
To buy Gennex Laboratories Ltd shares, you need to follow these steps:
Gennex Laboratories Ltd trading volume is 5.09L as on . This means that 5.09L shares of Gennex Laboratories Ltd were bought and sold on the stock market during today's trading session.